Loading…
Ardelyx, Inc. is projected to rise to $7.62 by 2027, a +24% move from its current price of $6.17. ARDX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $6.02 | $6.17 | $6.32 | +0.03% |
| May 30 | $5.97 | $6.17 | $6.39 | +0.05% |
| May 31 | $5.92 | $6.18 | $6.44 | +0.08% |
| Jun 1 | $5.88 | $6.18 | $6.48 | +0.11% |
| Jun 2 | $5.85 | $6.18 | $6.52 | +0.14% |
| Jun 3 | $5.82 | $6.18 | $6.56 | +0.16% |
| Jun 4 | $5.80 | $6.18 | $6.59 | +0.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.80 | $6.18 | $6.59 | +0.19% |
| Week 2 | $5.66 | $6.19 | $6.78 | +0.38% |
| Week 3 | $5.55 | $6.21 | $6.93 | +0.57% |
| Week 4 | $5.47 | $6.22 | $7.07 | +0.76% |
| Week 5 | $5.40 | $6.23 | $7.19 | +0.95% |
| Week 6 | $5.33 | $6.24 | $7.30 | +1.14% |
| Week 7 | $5.28 | $6.25 | $7.41 | +1.34% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Ardelyx, Inc. is a healthcare company that discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis.
Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Ardelyx, Inc. (ARDX) is a healthcare stock with a current price of $6.11 and a market cap of $1.51B. Its market rank is 2227.
The stock carries an annualized volatility of 50%, reflecting elevated swings in its price. This snapshot provides a baseline for evaluating the near-term and longer-term price trajectories that are indicated in the forecast.”
From the forecast data, the average price for 2026 is $6.11, rising to $9.07 by 2030 and to $40.62 by 2050, with bullish sentiment beginning in 2027. The sequence notes a progressive upside with higher annual averages in later years, including a 2040 average of $21.31 and a 2032 average of $12.20.
Forecasted ROIs outline a path of growth: 2027 23.1%, 2028 27.3%, 2029 35.8%, 2030 48.5%, 2031 58.1%, 2032 99.7%, 2033 123.2%, 2034 114.3%, 2035 131.5%, 2040 248.8%, and 2050 564.8%.
A major floor 17.0% below — a decisive break under it would weaken the trend.
The nearest floor, 3.6% below — buyers have tended to step in here.
The nearest ceiling, 18.3% above — a clean break opens room to run.
A major ceiling 29.5% above — clearing it would confirm fresh momentum.
Key ARDX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ARDX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.23 | Sell | $6.21 | Sell |
| MA 10 | $6.24 | Sell | $6.28 | Sell |
| MA 20 | $6.51 | Sell | $6.34 | Sell |
| MA 50 | $6.15 | Buy | $6.31 | Sell |
| MA 100 | $6.50 | Sell | $6.26 | Sell |
| MA 200 | $6.14 | Buy | $6.05 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.59 | Neutral |
| Stoch RSI (14) | 15.31 | Buy |
| CCI (20) | -67.57 | Neutral |
| Williams %R (14) | -91.01 | Info |
| MACD (12,26,9) | -0.06 | Sell |
| ROC (12) | -9.00 | Sell |
| Bollinger %B (20,2) | 0.28 | Neutral |
| Stochastic %K (14) | 8.99 | Buy |
| TRIX (15) | 0.10 | Buy |
| Awesome (5,34) | -0.13 | Sell |
| Ultimate (7,14,28) | 40.79 | Neutral |
| Momentum (10) | -0.44 | Sell |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 6.21 | Sell |
| ADX (14) | 13.00 | Neutral |
| ATR (14) | 0.14 | Info |
The near-term technical picture is NEUTRAL.
RSI (14) is 40, with the stock trading around its short- and long-term moving averages. The 50-day simple moving average is $6.14, and the 200-day simple moving average is $6.13, keeping prices within a narrow band near key averages. Support is pegged at $5.95 while resistance sits at $7.30.
The 30-day range runs from $5.18 to $7.21, indicating a contained trading window in the month ahead.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.31 | $6.17 | $8.37 | 0% | Neutral | |
| $6.11 | $7.62 | $10.03 | +24% | Bullish | |
| $6.17 | $7.88 | $10.71 | +28% | Bullish | |
| $6.46 | $8.42 | $11.73 | +36% | Bullish | |
| $7.01 | $9.30 | $13.25 | +51% | Bullish | |
| $7.33 | $9.88 | $14.35 | +60% | Bullish | |
| $9.04 | $12.37 | $18.27 | +100% | Bullish | |
| $10.04 | $13.93 | $20.90 | +126% | Bullish | |
| $9.57 | $13.45 | $20.47 | +118% | Bullish | |
| $10.15 | $14.45 | $22.29 | +134% | Bullish | |
| $14.53 | $21.90 | $35.74 | +255% | Bullish | |
| $25.14 | $41.75 | $74.01 | +577% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $5.31 | $6.17 | $7.27 | +0.00% |
| June 2026 | $5.42 | $6.35 | $7.61 | +2.98% |
| July 2026 | $5.36 | $6.32 | $7.66 | -0.47% |
| August 2026 | $5.41 | $6.43 | $7.86 | +1.63% |
| September 2026 | $5.58 | $6.66 | $8.21 | +3.59% |
| October 2026 | $5.56 | $6.67 | $8.27 | +0.14% |
| November 2026 | $5.45 | $6.56 | $8.19 | -1.60% |
| December 2026 | $5.52 | $6.67 | $8.37 | +1.66% |
Click any year to see its month-by-month ARDX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ARDX is projected to trade between $5.31 and $8.37, averaging $6.17 — a potential gain of 0% from today's $6.17. Price action looks broadly range-bound.
Ardelyx, Inc.'s 2027 outlook centres on $7.62, within a $6.11 to $10.03 range. That is up +24% on the projected 2026 average. That marks a +24% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, ARDX could reach as high as $10.71, with a base case around $7.88 and support toward $6.17 — roughly +28% from $6.17. Momentum favours further upside here.
Expect ARDX to range from $6.46 to $11.73 through 2029. The $8.42 average target implies a +36% move from current prices. That is up +7% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The ARDX price prediction for 2030 points to an average of $9.30 (low $7.01, high $13.25) — a potential gain of +51% on today's $6.17. Momentum favours further upside here.
In 2031, ARDX is projected to trade between $7.33 and $14.35, averaging $9.88 — a potential gain of +60% from today's $6.17. That is up +6% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Ardelyx, Inc.'s 2032 outlook centres on $12.37, within a $9.04 to $18.27 range. That is up +25% on the projected 2031 average. That marks a +100% change versus current levels. Momentum favours further upside here.
By 2033, ARDX could reach as high as $20.90, with a base case around $13.93 and support toward $10.04 — roughly +126% from $6.17. Buyers look set to stay in control over this stretch.
Expect ARDX to range from $9.57 to $20.47 through 2034. The $13.45 average target implies a +118% move from current prices. That is -3% versus the projected 2033 average. Momentum favours further upside here.
The ARDX price prediction for 2035 points to an average of $14.45 (low $10.15, high $22.29) — a potential gain of +134% on today's $6.17. Buyers look set to stay in control over this stretch.
In 2040, ARDX is projected to trade between $14.53 and $35.74, averaging $21.90 — a potential gain of +255% from today's $6.17. That is up +52% on the projected 2035 average. Momentum favours further upside here.
Ardelyx, Inc.'s 2050 outlook centres on $41.75, within a $25.14 to $74.01 range. That is up +91% on the projected 2040 average. That marks a +577% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in ARDX today (≈ 162.074554 ARDX) could be worth
$6,767.23
+$5,767.23 (+577%) by 2050 · US Dollar
Based on the average projected ARDX price of $41.75 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ARDXwould be worth at today's price.
$1,000 invested in ARDX on May 27, 2025 (≈ 251.889167 ARDX) would be worth
$1,554.16
+$554.16 (+55.4%) today · 1.55× · US Dollar
Based on a ARDX entry price of $3.97 vs. today's $6.17.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.27 | $984.05 | -1.6% |
| 1 month ago | $5.99 | $1,030.05 | +3.0% |
| 3 months ago | $6.63 | $930.62 | -6.9% |
| 6 months ago | $5.8 | $1,063.79 | +6.4% |
| 1 year ago | $3.97 | $1,554.16 | +55.4% |
| All time (5.0y) ago | $7.15 | $862.94 | -13.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ARDX forecast.
Our base-case forecast reaches $12.00 around 2032.
Implied market cap at $12.00: $2.96B
The multi-year forecast shows a bullish trajectory across later years, with rising averages and expanding upside. The 2026 average is $6.11, climbing to a projected $9.07 by 2030, then to $21.31 by 2040 and $40.62 by 2050, reflecting a substantial long-run upside.
The forecasted ROI strengthens over time, reaching 23.1% in 2027, 27.3% in 2028, 35.8% in 2029, 48.5% in 2030, 58.1% in 2031, 99.7% in 2032, 123.2% in 2033, 114.3% in 2034, 131.5% in 2035, 248.8% in 2040, and 564.8% in 2050. Sentiment shifts to BULLISH from 2027 onward, with a NEUTRAL reading in 2026.
As with any forecast, these figures are estimates and not guarantees; actual results may differ due to a range of market and company-specific factors.
Tap a question to reveal the answer.
The 2030 average price is projected at $9.07 with a maximum of $13.03 and a minimum of $6.80, and an estimated ROI of 48.5%. The forecast sentiment for 2030 is BULLISH.
The forecast shows a bullish trajectory from 2027 onward, with rising average prices (e.g., $7.52 in 2027, $9.07 in 2030) and increasing ROIs (up to 58.1% in 2031 and 564.8% by 2050). The 2026 reading is NEUTRAL.
Yes. The 2050 maximum is $72.98, which includes a path that could exceed $50 within the forecast horizon, with a 2050 maximum of $72.98 and 2050 average of $40.62.
Current price is $6.11 and market cap is $1.51B.
The 30-day range is $5.18 to $7.21. RSI(14) is 40. The 50-day SMA is $6.14 and the 200-day SMA is $6.13. Support is at $5.95 and resistance at $7.30.
Ardelyx, Inc. Community Discussion
0Share your Ardelyx, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.